Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
Submitted by
admin
on October 13, 2017 - 9:52am
Source:
Endpoints
News Tags:
Sanofi
myelofibrosis
fedratinib
Impact Biomedicines
Headline:
Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib
Do Not Allow Advertisers to Use My Personal information
